Business

Press Release Jun 03 2026

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection".

Natco Pharma LimitedJune 3, 20265
Press Release Jun 03 2026

About this update from Natco Pharma Limited

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection". View Attachment

View stock analysis, news, and events for Natco Pharma Limited

More from Natco Pharma Limited

Natco Pharma Limited Press Release Aug 25 2026

August 25, 2026

Natco Pharma Limited Press Release Aug 21 2026

August 21, 2026

All Natco Pharma Limited news →